BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31745392)

  • 1. Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke.
    Paulin BK; Cedric KK; Tamomh AG; Hui YD
    Int J Health Sci (Qassim); 2019; 13(6):3-12. PubMed ID: 31745392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of CHA
    Cheng X; Liu L; Li L; Zhao H; Li J; Shi J; Zhang W
    Intern Emerg Med; 2021 Aug; 16(5):1155-1163. PubMed ID: 33386603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.
    Ruff CT; Giugliano RP; Braunwald E; Murphy SA; Brown K; Jarolim P; Mercuri M; Antman EM; Morrow DA
    JAMA Cardiol; 2016 Dec; 1(9):999-1006. PubMed ID: 27706467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of B-Type Natriuretic Peptide Level on Risk Stratification of Thromboembolism and Death in Patients With Nonvalvular Atrial Fibrillation - The Hokuriku-Plus AF Registry.
    Hayashi K; Tsuda T; Nomura A; Fujino N; Nohara A; Sakata K; Konno T; Nakanishi C; Tada H; Nagata Y; Teramoto R; Tanaka Y; Kawashiri MA; Yamagishi M;
    Circ J; 2018 Apr; 82(5):1271-1278. PubMed ID: 29491320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of D-dimer and left atrial size combined with CHA
    Wu CC; Li XB; Duan JB; He JS; Zhu TG; Yu C; Li D; Ze F; Guo JH; Wang L
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(48):3938-3943. PubMed ID: 34954995
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
    Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA
    Roldán V; Rivera-Caravaca JM; Shantsila A; García-Fernández A; Esteve-Pastor MA; Vilchez JA; Romera M; Valdés M; Vicente V; Marín F; Lip GYH
    Ann Med; 2018 Feb; 50(1):26-34. PubMed ID: 28892413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
    Yang LT; Tsai WC; Su HM
    Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.
    Shang L; Zhang L; Guo Y; Sun H; Zhang X; Bo Y; Zhou X; Tang B
    Front Cardiovasc Med; 2021; 8():682538. PubMed ID: 34277733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.